Risk factor
Poor trading liquidity
Profitability factor
Very favourable analyst view
About
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables the accurate and efficient analysis of elements such as gold, silver, and copper, among others.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of C79.AX is 9.4 and suggests 64.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc